China Traditional Chinese Medicine Holdings Co. Ltd. is a high-risk pharmaceutical company based in Hong Kong. With a risk rating score of 39.0, the company operates through four segments - Yi Fang, Tian Jiang, Tong Ji Tang, and Medi-World. Specializing in Traditional Chinese Medicine, it generates revenue mainly from the manufacture and sales of concentrated TCM granules, healthcare products, and decoction pieces. The majority of its revenue comes from Mainland China. The company's focus on ESG practices showcases its commitment to environmental sustainability and good governance.